Details

---

• Marketing Authorization (Malaysia): MAL15065037AZ, indicating approval by the Malaysian National Pharmaceutical Regulatory Agency (NPRA).

• Manufacturer: Merck Sante S.A.S., France; marketed and distributed in Malaysia by Merck Sdn. Bhd.

Content

• Active Ingredient: Each extended-release tablet contains 1000 mg metformin hydrochloride, corresponding to 780 mg metformin base.

• Excipients: For a full list of excipients, please refer to the product's Summary of Product Characteristics.

• Formulation: White to off-white, capsule-shaped, biconvex tablet, debossed on one side with '1000' and on the other side with 'Merck'.

• Pack Size: 60 tablets.

• Manufacturer: Merck Sante S.A.S., France; marketed and distributed in Malaysia by Merck Sdn. Bhd.

Indications

Glucophage XR 1000mg Tablets are indicated for:

• Monotherapy or combination therapy with other oral antidiabetic agents or insulin for the treatment of type 2 diabetes mellitus in adults when dietary management and exercise alone do not result in adequate glycaemic control.

• Reduction of the risk or delay of the onset of type 2 diabetes mellitus in overweight adults with impaired glucose tolerance (IGT), impaired fasting glucose (IFG), and/or increased HbA1c who are at high risk for developing overt type 2 diabetes mellitus and still progressing towards type 2 diabetes mellitus despite implementing intensive lifestyle changes for 3–6 months.

Instructions for Use

• Dosage:

  • Adults with normal renal function (GFR ≥90 mL/min):

    • The usual starting dose is 500 mg taken once daily with the evening meal.

    • After 10 to 15 days, the dose should be adjusted based on blood glucose measurements.

    • The maximum recommended dose is 2000 mg daily, taken as a single dose with the evening meal.

  • Transfer from other oral antidiabetic agents:

    • Discontinue the other agent and initiate Glucophage XR at the same daily dose.

  • Combination with insulin:

    • Initiate Glucophage XR at 500 mg daily with the evening meal.

    • Adjust the insulin dose based on blood glucose measurements.

• Administration:

  • Swallow the tablet whole with water. Do not chew, crush, or break the tablet. mims.com

  • It is recommended to take the medication at the same time each day, preferably with the evening meal. mims.com

• Precautions:

  • Contraindicated in patients with hypersensitivity to metformin, metabolic acidosis, diabetic coma, or severely impaired renal function (GFR <30 mL/min).

  • Use with caution in patients with renal or hepatic impairment.

  • Temporarily discontinue use if dehydration occurs or in the presence of conditions that alter renal function.

  • Monitor renal function regularly during treatment.

  • Avoid alcohol consumption during treatment.